LATEST

Off the Wire

IN FOCUS

What a Massive Study of 12 Million Says About Breast Cancer Screening, Rates

A recent study, remarkable for its sheer sample size, sheds light on the escalating issue of breast cancer among women in China, highlighting a noticeable uptick in...

Nanotechnology-Enhanced Resveratrol Shows Promise in Treatment of Triple-Negative Breast Cancer

Yes, it's that kind of resveratrol--that found in red wine. But with a technical twist to ensure it's delivered properly. Triple-negative breast cancer (TNBC) is a type of...

Turning Cancer’s Acidity Against Itself Without Harming Healthy Tissue

A team of researchers from Vanderbilt University and Vanderbilt University Medical Center has developed a groundbreaking method to destroy tumors by disrupting their acidic environment, which is...

LEARN MORE

RESEARCH

RESEARCH

LEARN MORE

Second Chances at a Price: The High Stakes of Reoperation in Breast Cancer

A recent study published in the Annals of Surgical Oncology, has brought attention to a concerning trend in the treatment of breast cancer, specifically...

Atossa Therapeutics Hits Milestone in Breast Cancer Trial with Full Enrollment

Atossa Therapeutics Inc has recently made an announcement about progress in one of its breast cancer studies. They've completed enrolling participants for a specific...

BriaCell Reveals Notable Results in Breast Cancer Treatment Trials

BriaCell Therapeutics Corp., a biotech firm focused on developing new treatments for cancer, recently shared promising results from their studies on breast cancer treatments....

Elacestrant Unveiled: A New Horizon for Hormone-Driven Breast Cancer

Patients with a type of breast cancer that grows in response to estrogen (ER-positive) but does not have the HER2 protein (HER2-negative) often start...

BCI Test Predicts Breast Cancer Recurrence Risk in Hormone Therapy Patients

The Breast Cancer Index (BCI) has been validated as a tool for predicting the risk of breast cancer recurrence in postmenopausal women treated with...

DRUG DEVELOPMENT